LYOCELL Trademark

Trademark Overview


On Friday, February 22, 2002, a trademark application was filed for LYOCELL with the United States Patent and Trademark Office. The USPTO has given the LYOCELL trademark a serial number of 76373277. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 24, 2014. This trademark is owned by Lyotropic Therapeutics, Inc.. The LYOCELL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations consisting of nano and micro particles that contain bioactive agents and utilize lyotropic liquids and liquid crystals, and ingredients and components thereof for use in prevention and treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, circulatory system and blood, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central, peripheral, autonomous, sympathetic and parasympathetic nervous system, diseases or conditions of the muscle and motor system, diseases and conditions of the skeletal system and bone, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders, hormonal disorders, protein disorders, genetic disorders, immune system, and gynecological conditions; for use in the alleviation or prevention or suppression of pain and the administration of anesthesia,...
lyocell

General Information


Serial Number76373277
Word MarkLYOCELL
Filing DateFriday, February 22, 2002
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 24, 2014
Registration Number2824420
Registration DateTuesday, March 23, 2004
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 30, 2003

Trademark Statements


Goods and ServicesPharmaceutical preparations consisting of nano and micro particles that contain bioactive agents and utilize lyotropic liquids and liquid crystals, and ingredients and components thereof for use in prevention and treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, circulatory system and blood, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central, peripheral, autonomous, sympathetic and parasympathetic nervous system, diseases or conditions of the muscle and motor system, diseases and conditions of the skeletal system and bone, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders, hormonal disorders, protein disorders, genetic disorders, immune system, and gynecological conditions; for use in the alleviation or prevention or suppression of pain and the administration of anesthesia, antipyretics, and anti-inflammatory agents, veterinary preparations consisting of nano and micro particles containing bioactive agents and utilize lyotropic liquids and liquid crystals, and ingredients and components thereof for use in prevention and treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, circulatory system and blood, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central, peripheral, autonomous, sympathetic and parasympathetic nervous system, diseases or conditions of the muscle and motor system, diseases and conditions of the skeletal system and bone, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders, hormonal disorders, protein disorders, genetic disorders, immune system, and gynecological conditions; for use in the alleviation or prevention or suppression of pain and the administration of anesthesia, antipyretics and anti-inflammatory agents
Pseudo MarkLYOTROPIC CELL

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 24, 2014
Primary Code005
First Use Anywhere DateSunday, April 30, 2000
First Use In Commerce DateSunday, April 30, 2000

Trademark Owner History


Party NameLyotropic Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAshland, VA 23005

Party NameLyotropic Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAshland, VA 23005

Party NameLyotropic Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAshland, VA 23005

Trademark Events


Event DateEvent Description
Friday, October 24, 2014CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Tuesday, May 14, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 31, 2010REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, March 31, 2010CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, March 19, 2010TEAS SECTION 8 & 15 RECEIVED
Tuesday, March 23, 2004REGISTERED-PRINCIPAL REGISTER
Tuesday, December 30, 2003PUBLISHED FOR OPPOSITION
Wednesday, December 10, 2003NOTICE OF PUBLICATION
Monday, September 15, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 20, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 21, 2003PAPER RECEIVED
Wednesday, August 20, 2003PAPER RECEIVED
Tuesday, August 19, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 27, 2003CASE FILE IN TICRS
Tuesday, August 19, 2003FAX RECEIVED
Thursday, February 20, 2003UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Thursday, February 20, 2003NON-FINAL ACTION E-MAILED
Tuesday, December 17, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 17, 2002PAPER RECEIVED
Friday, October 18, 2002ASSIGNED TO EXAMINER
Thursday, June 27, 2002NON-FINAL ACTION MAILED
Wednesday, June 12, 2002ASSIGNED TO EXAMINER